Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SHAPE10
- Development stage
- Unknown
- Lead developer
- Hugel
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Injection
01
Overview
SHAPE10 is a cross-linked hyaluronic acid (HA) filler developed by Hugel, specifically designed for male aesthetic enhancement. It is indicated for penile enlargement (augmentation), providing a non-surgical option for increasing girth. The product utilizes the high viscosity and elasticity of cross-linked hyaluronic acid to provide immediate physical volumization and structural support upon injection into the penile fascia. SHAPE10 received regulatory approval in South Korea in 2017, expanding Hugel's portfolio of medical aesthetic products beyond facial fillers and botulinum toxins.
- Brand names
- SHAPE10SHAPE-10SHAPE 10
Beyond the preview
Go deeper on SHAPE10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SHAPE10.